Correction: Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study
Year: 2024
Type: erratum
Source: Annals of Surgical Oncology
Authors: Jonathan S. Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J. Eschelman, Evan S. Glazer, Aslam Ejaz, J. Harrison Howard, Erika Richtig, Sebastian Ochsenreither, Sunil A. Reddy, Michael C. Lowe, Georgia M. Beasley, Anja Gesierich, Armin Bender, Martin Gschnell, Reinhard Dummer, Michel Rivoire, Ana Arance, Stephen William Fenwick, Joseph J. Sacco, Sebastian Haferkamp, Carsten Weishaupt, Johnny John, Matthew Wheater, Christian H. Ottensmeier
Institutions: University of South Florida, Moffitt Cancer Center, Thomas Jefferson University, European Institute of Oncology, University of Tennessee Health Science Center, The Ohio State University, University of South Alabama, Medical University of Graz, Charité – Universitätsmedizin Berlin, Stanford University, Emory University, Duke University, Universitätsklinikum Würzburg, Universitätsklinikum Gießen und Marburg, University Hospital Zurich, Centre Léon Bérard, Hospital Clínic de Barcelona, Liverpool University Hospitals NHS Foundation Trust, University of Liverpool, University Hospital Regensburg, University Hospital Münster, Delcath Systems (United States), University Hospital Southampton NHS Foundation Trust
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,390
OpenAlex ID: W4400774058